Geoffrey P. Judge - 30 Apr 2024 Form 4 Insider Report for Everi Holdings Inc. (EVRI)

Role
Director
Signature
/s/ Geoffrey P. Judge by Todd A. Valli, Attorney-in-Fact
Issuer symbol
EVRI
Transactions as of
30 Apr 2024
Net transactions value
-$47,400
Form type
4
Filing time
02 May 2024, 21:39:55 UTC
Previous filing
01 Dec 2023
Next filing
15 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVRI Common Stock Options Exercise $197,700 +30,000 +33% $6.59 121,572 30 Apr 2024 Direct F1
transaction EVRI Common Stock Sale $245,100 -30,000 -25% $8.17 91,572 30 Apr 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVRI Stock Option Options Exercise $0 -30,000 -100% $0.000000* 0 30 Apr 2024 Common Stock 30,000 $6.59 Direct F3
transaction EVRI Restricted Stock Units Award $0 +10,700 $0.000000 10,700 01 May 2024 Common Stock 10,700 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on March 10, 2023 for options originally granted on May 2, 2014 that would have expired on May 2, 2024.
F2 The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $8.01 to $8.35. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents an option to purchase 50,000 shares of the Company's common stock, which vested periodically over a period of four years following the date of grant of May 2, 2014.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 Represents restricted stock units to acquire shares of the Company's common stock that will vest on the first anniversary date following the grant date of May 1, 2024. These vested shares will be settled and delivered to the reporting person on the earliest of the following events: (i) May 1, 2034; (ii) the reporting person's death; (iii) the occurrence of a Change in Control (as defined in our equity incentive plans), subject to qualifying conditions; and (iv) the date that is six (6) months following the reporting person's separation from service, subject to qualifying conditions.